Omega-3 trial finds a bone-marker difference in children with leukemia
Adding omega-3 to vitamin D and calcium lowered a marker of bone breakdown, but the abstract does not establish stronger bones or fewer fractures.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
Children receiving added omega-3 had a lower blood concentration of ICTP, a bone breakdown marker, at the final assessment. Vitamin D concentrations increased in both groups, with no additional effect reported from omega-3. These results concern blood markers and do not establish fewer fractures, stronger bones, or better everyday functioning.
This abstract-based explanation concerns a small pediatric leukemia trial. The abstract does not report fracture outcomes or bone strength, so its broader conclusion about bone health extends beyond the directly described measurements.
What researchers found
Blood ICTP concentration
At 12 weeks, omega-3 plus vitamin D and calcium versus vitamin D and calcium alone.
What the comparison tests
Both groups received vitamin D and calcium. The randomized comparison therefore addresses the added contribution of omega-3 within that supplement combination, rather than the effect of the full combination compared with receiving no supplements.
Why the endpoint matters
ICTP was measured as an indicator of bone breakdown. A difference in this marker can inform the biological question, but the abstract provides no direct evidence that the children experienced fewer skeletal problems.
The original publication
Impact of Omega-3 and Vitamin D Supplementation on Bone Turnover Markers in Children with Leukemia: Follow-Up During and After Supplementation.
Barbosa-Cortés L, Morales-Montes SB, Maldonado-Alvarado M et al.
Nutrients · 2025
- PubMed ID
- 40806109
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.